AR and posterior cortical atrophy: Regrettably, a common occurrence following multiple cycles of hormone therapy is the transition of hormone-sensitive PCa to castration-resistant PCa, characterized by low serum testosterone levels concurrent with activation of the androgen receptor (AR) signaling pathway [3].